Wealthfront Advisers’s AXS Cannabis ETF THCX Stock Holding History

Wealthfront Advisers’s Portfolio THCX Stock Details THCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,105	Closed	-$187K	–	886
2023 Q4	$187K	Buy	+11,105	New	+$184K	﹤0.01%	844
2023 Q3	–	Sell	-9,956	Closed	-$170K	–	846
2023 Q2	$170K	Buy	9,956 +862	+9%	+$16.4K	﹤0.01%	817
2023 Q1	$196K	Buy	9,094 +1,757	+24%	+$44.1K	﹤0.01%	798
2022 Q4	$190K	Sell	7,337 -55	-0.7%	-$1.64K	﹤0.01%	772
2022 Q3	$205K	Buy	7,392 +1,870	+34%	+$68.6K	﹤0.01%	750
2022 Q2	$204K	Buy	5,522 +2,189	+66%	+$115K	﹤0.01%	754
2022 Q1	$252K	Sell	3,333 -724	-18%	-$53.7K	﹤0.01%	732
2021 Q4	$346K	Buy	4,057 +1,376	+51%	+$151K	﹤0.01%	651
2021 Q3	$344K	Buy	+2,681	New	+$394K	﹤0.01%	604

Wealthfront Advisers's THCX Position: Q1 2024 in Review

Wealthfront Advisers sold out of AXS Cannabis ETF (THCX) in Q1 2024, closing a stake of 11,105 shares — an estimated $187K sold.

Wealthfront Advisers first reported a position in THCX in Q3 2021 and held it in 9 quarters. The position peaked at $346K in Q4 2021. 0 funds tracked by Wall St. Rank hold THCX as of Q1 2024.

Wealthfront Advisers reported no remaining AXS Cannabis ETF position as of Q1 2024 after selling out during the quarter.
Wealthfront Advisers sold 11,105 AXS Cannabis ETF shares in Q1 2024, an estimated $187K.
Wealthfront Advisers first reported a position in AXS Cannabis ETF in Q3 2021 and held it in 9 quarters.
Wealthfront Advisers's AXS Cannabis ETF position peaked at $346K in Q4 2021.
0 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q1 2024.

Based on Wealthfront Advisers's 13F filing for Q1 2024, filed 19 Apr 2024.